Traws Pharma, Inc. (TRAW) News
Follow Traws Pharma, Inc. (TRAW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
TRAW - Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
TRAW - Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
EARNINGS | Aug 14, 2026, 08:30 PM UTC
L
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
EQUITY | Jul 02, 2026, 01:18 PM UTC
L
Traws PharmaFiles Prospectus For Mixed Shelf Offering Of Up To ~$139.2M
Traws Pharma, Inc. $139,185,641.25 Common Stock Preferred Stock Debt Securities Warrants Units This prospectus covers our offer and sale from time to time of any combination of common stock, preferred stock, debt securit
EQUITY | Jul 01, 2026, 08:05 PM UTC
M
TRAW Updates Guidance
Traws Pharma provides updated guidance on influenza prophylaxis program with resubmission of data package to MHRA expected in 3Q 2026
EQUITY | Jun 22, 2026, 11:01 AM UTC